Skip to main content
Clinical Trials/NCT01640366
NCT01640366
Completed
Not Applicable

A Prospective, Randomized, Intra-patient, Comparative, Open, Multi-centre Study to Evaluate the Efficacy of a Single-Use NPWT System on the Prevention of Incision Healing Complications in Patients Undergoing Reduction Mammoplasty

Smith & Nephew, Inc.6 sites in 4 countries200 target enrollmentJune 2012
ConditionsDelayed Healing

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delayed Healing
Sponsor
Smith & Nephew, Inc.
Enrollment
200
Locations
6
Primary Endpoint
Number of Participants Experiencing Incision Healing Complications up to Day 21 Postoperatively
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to see if the use of a single-use negative pressure wound therapy system (NPWT) will have an effect on the reduction of post-surgical incision healing complications following breast reduction surgery and to assess the medium-term aesthetic appearance and quality of the resultant scar, compared with standard of care dressings.

Detailed Description

The aim of the present study is to assess the efficacy and cost-effectiveness of the Single-Use Negative Pressure Wound Therapy (NPWT) system (PICO) with regard to the reduction of postsurgical incision healing complications during the immediate postoperative treatment phase, and to assess the medium-term aesthetic appearance and quality of the resultant scar, in patients undergoing reduction mammoplasty, compared to standard care.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
July 2014
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female patient's ≥ 18 years old
  • The patient is able to understand the trial and is willing to consent to the trial
  • Patient has undergone an elective surgical procedure for bilateral reduction mammoplasty
  • Patients postsurgical incisions are of similar length

Exclusion Criteria

  • Pregnant or lactating females
  • Patients on steroids or other immune modulators known to impact healing which may affect scar appearance
  • Patients with tattoos in the area of the incisions
  • Patients with skin conditions (Cutis laxa etc.) that would result in poor healing or widened scars
  • Patients with a known significant history of scar problems i.e. hypertrophic scaring or keloids
  • Patients who in the opinion of the investigator may not complete the study for any reason
  • Patients with a known history of poor compliance with medical treatment
  • Patients who have participated in this trial previously and who were withdrawn
  • Patients with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing)
  • Incisions that are actively bleeding

Outcomes

Primary Outcomes

Number of Participants Experiencing Incision Healing Complications up to Day 21 Postoperatively

Time Frame: 21 days postoperatively

The primary variable of whether or not the incision developed a healing complication within 21 days of surgery was defined as the presence of at least one of the following: 1. Infection (superficial or deep), 2. Dehiscence (partial, superficial or deep), 3. Delayed healing (defined as incision not closed within 7 days of the first surgical procedure). All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.

Secondary Outcomes

  • Number of Participants Experiencing Postsurgical Incision Healing Complications (Dehiscence) Occurring up to Day 21 Postoperatively(21 days postoperatively)
  • Number of Participants Experiencing Postsurgical Incision Healing Complications (Infection) Occurring up to Day 21 Postoperatively(21 days postoperatively)
  • Number of Hematoma's Occurring up to and 21 Days Postoperatively(21 days postoperatively)
  • Number of Wounds Showing 100% Closure Occurring up to and 21 Days Postoperatively(21 days postoperatively)
  • Aesthetic Appearance (Cosmesis) and Scar Quality at 90 Days Postoperatively(90 days postoperatively)
  • Number of Participants Experiencing Postsurgical Incision Healing Complications (Delayed Healing) Occurring Within 10 Days Postoperatively(Within 10 days postoperatively)
  • Number of Participants Experiencing Postsurgical Incision Healing Complications (Delayed Healing) Occurring Within 7 Days Postoperatively(Within 7 days postoperatively)
  • Number of Skin, Nipple and Areola Necrosis Occurring up to and 21 Days Postoperatively(21 days postoperatively)

Study Sites (6)

Loading locations...

Similar Trials